Merck KGaA (OTCMKTS:MKKGY) Short Interest Down 88.9% in March

Merck KGaA (OTCMKTS:MKKGY) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 900 shares, a decrease of 88.9% from the February 28th total of 8,100 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 129,800 shares, the days-to-cover ratio is presently 0.0 days.

Merck KGaA Stock Down 3.6 %

Shares of OTCMKTS:MKKGY traded down $1.03 during trading on Thursday, hitting $27.23. 47,833 shares of the company’s stock traded hands, compared to its average volume of 126,469. The company has a current ratio of 1.33, a quick ratio of 0.91 and a debt-to-equity ratio of 0.28. The company has a 50-day moving average price of $29.18 and a 200-day moving average price of $31.07. Merck KGaA has a 52 week low of $27.19 and a 52 week high of $39.17. The company has a market cap of $17.60 billion, a price-to-earnings ratio of 16.81, a price-to-earnings-growth ratio of 2.05 and a beta of 0.98.

Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earnings results on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. The firm had revenue of $5.78 billion for the quarter, compared to analyst estimates of $5.40 billion. As a group, research analysts forecast that Merck KGaA will post 1.87 EPS for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.